117 related articles for article (PubMed ID: 11907326)
1. Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species.
Aggarwal N; Barnett PV
J Gen Virol; 2002 Apr; 83(Pt 4):775-782. PubMed ID: 11907326
[TBL] [Abstract][Full Text] [Related]
2. Two Cross-Protective Antigen Sites on Foot-and-Mouth Disease Virus Serotype O Structurally Revealed by Broadly Neutralizing Antibodies from Cattle.
Li K; He Y; Wang L; Li P; Wang S; Sun P; Bao H; Cao Y; Liu X; Zhu G; Song Y; Bai X; Ma X; Fu Y; Yuan H; Zhang J; Wang J; Chen Y; Li D; Lou Z; Liu Z; Lu Z
J Virol; 2021 Oct; 95(21):e0088121. PubMed ID: 34406868
[TBL] [Abstract][Full Text] [Related]
3. Foot-and-mouth disease virus epitope dominance in the antibody response of vaccinated animals.
Mahapatra M; Hamblin P; Paton DJ
J Gen Virol; 2012 Mar; 93(Pt 3):488-493. PubMed ID: 22158876
[TBL] [Abstract][Full Text] [Related]
4. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
[TBL] [Abstract][Full Text] [Related]
5. Differential antibody responses to the major antigenic sites of FMD virus serotype O after primo-vaccination, multiply-vaccination and after natural exposure.
Biswal JK; Subramaniam S; Ranjan R; VanderWaal K; Sanyal A; Pattnaik B; Singh RK
Infect Genet Evol; 2020 Mar; 78():104105. PubMed ID: 31706082
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
[TBL] [Abstract][Full Text] [Related]
7. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
[TBL] [Abstract][Full Text] [Related]
9. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
Fowler VL; Paton DJ; Rieder E; Barnett PV
Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
[TBL] [Abstract][Full Text] [Related]
10. Development of Foot-and-Mouth Disease Virus-Neutralizing Monoclonal Antibodies Derived From Plasmablasts of Infected Cattle and Their Germline Gene Usage.
Li K; Wang S; Cao Y; Bao H; Li P; Sun P; Bai X; Fu Y; Ma X; Zhang J; Li D; Chen Y; Liu X; An F; Wu F; Lu Z; Liu Z
Front Immunol; 2019; 10():2870. PubMed ID: 31867017
[TBL] [Abstract][Full Text] [Related]
11. Antigenic site variation in foot-and-mouth disease virus serotype O grown under vaccinal serum antibodies in vitro.
Sarangi LN; Mohapatra JK; Subramaniam S; Sanyal A; Pattnaik B
Virus Res; 2013 Sep; 176(1-2):273-9. PubMed ID: 23850868
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
[TBL] [Abstract][Full Text] [Related]
14. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
Gullberg M; Lohse L; Bøtner A; McInerney GM; Burman A; Jackson T; Polacek C; Belsham GJ
PLoS One; 2016; 11(6):e0157435. PubMed ID: 27294397
[TBL] [Abstract][Full Text] [Related]
15. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.
Fowler VL; Knowles NJ; Paton DJ; Barnett PV
Vaccine; 2010 Apr; 28(19):3428-34. PubMed ID: 20199761
[TBL] [Abstract][Full Text] [Related]
16. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
De Vleeschauwer AR; Zhou X; Lefebvre DJ; Garnier A; Watier F; Pignon C; Lacour SA; Zientara S; Bakkali-Kassimi L; De Clercq K; Klonjkowski B
Vaccine; 2018 Apr; 36(16):2193-2198. PubMed ID: 29544690
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin.
Cui B; Liu X; Zhou P; Fang Y; Zhao D; Zhang Y; Wang Y
Appl Microbiol Biotechnol; 2019 Apr; 103(8):3367-3379. PubMed ID: 30888465
[TBL] [Abstract][Full Text] [Related]
18. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
[TBL] [Abstract][Full Text] [Related]
19. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
[TBL] [Abstract][Full Text] [Related]
20. Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV.
Rieder E; Baxt B; Lubroth J; Mason PW
J Virol; 1994 Nov; 68(11):7092-8. PubMed ID: 7523697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
